Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
220 participants
INTERVENTIONAL
2012-01-31
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Screening for Alcohol-related Cognitive Impairments in Cirrhotic Patients
NCT04490330
Characterization Imaging Instruments in Alcoholics and Non-Alcoholics
NCT02108080
Study of the BDNF-Val66Met Polymorphism in Alcohol-dependent Subjects in Relation to Abstinence After Withdrawal
NCT02146963
Study of Retinal Function Using Electroretinogram in Regular Alcohol Users
NCT03818971
Effects of Acetate and Alcohol on Brain Function
NCT02542150
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
FACTORIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
alcoholic patients
Neuropsychological testing
assessment of memory, executive functions and ataxia
blood draw
hepatic markers, red blood markers and vitamin markers
genetic testing
genes coding for thiamine enzymes (α-ketoglutarate dehydrogenase complex, transketolase et pyruvate dehydrogenase)
Brain imaging examination
MRI, DTI and PET examinations
korsakoff patients
Neuropsychological testing
assessment of memory, executive functions and ataxia
blood draw
hepatic markers, red blood markers and vitamin markers
genetic testing
genes coding for thiamine enzymes (α-ketoglutarate dehydrogenase complex, transketolase et pyruvate dehydrogenase)
Brain imaging examination
MRI, DTI and PET examinations
healthy controls
Neuropsychological testing
assessment of memory, executive functions and ataxia
blood draw
hepatic markers, red blood markers and vitamin markers
genetic testing
genes coding for thiamine enzymes (α-ketoglutarate dehydrogenase complex, transketolase et pyruvate dehydrogenase)
Brain imaging examination
MRI, DTI and PET examinations
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neuropsychological testing
assessment of memory, executive functions and ataxia
blood draw
hepatic markers, red blood markers and vitamin markers
genetic testing
genes coding for thiamine enzymes (α-ketoglutarate dehydrogenase complex, transketolase et pyruvate dehydrogenase)
Brain imaging examination
MRI, DTI and PET examinations
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age-normal corrected hearing and visual acuity
Exclusion Criteria
* history of medical or neurological illness or trauma potentially affecting the CNS, e.g., stroke, multiple sclerosis, epilepsy, psychosurgery, insulin coma.
* active tuberculosis or history of or any malignancy requiring chemotherapy
* history of schizophrenia or bipolar disorder
* metal implantation (e.g., pacemakers) or other factors that preclude MRI scanning for subjects selected for the neuroimaging examination
* meet DSM-IV criteria for current (past 3 months) other Substance Abuse
* met DSM-IV criteria for other Substance Dependence
* Have used other substances more than 5 times in the past month
21 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
National Research Agency, France
OTHER
University Hospital, Caen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Caen University Hospital
Caen, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11-050
Identifier Type: -
Identifier Source: secondary_id
2011-A00495-36
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.